ClinicaliQ Trial Snapshot
- Psilocybin in Functional Neurological Disorder — Active Not Recruiting • Non-phase study • Neurology • NCT05723276.
- Single psilocybin dose with therapy may alter brain network activity in functional neurological disorder patients.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The goal of this study is to learn about the brain network response in people who have functional neurological disorder who are administered with a single dose of the psychedelic psilocybin with therapeutic support. The main question it aims to answer is: Can the default mode network, a brain network thought to be relevent in FND, be modified by the administration of psilocybin based on functional magnetic resonance imaging before and after the dose? Conditions: Functional Neurological Disorder Interventions: Psilocybin Lead Sponsor: King's College London Planned Enrollment: 24 participants